Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Titel:
Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial
Auteur:
Allen, Jeffrey A Lin, Jie Basta, Ivana Dysgaard, Tina Eggers, Christian Guptill, Jeffrey T Gwathmey, Kelly G Hewamadduma, Channa Hofman, Erik Hussain, Yessar M Kuwabara, Satoshi Le Masson, Gwendal Leypoldt, Frank Chang, Ting Lipowska, Marta Lowe, Murray Lauria, Giuseppe Querol, Luis Simu, Mihaela-Adriana Suresh, Niraja Tse, Anissa Ulrichts, Peter Van Hoorick, Benjamin Yamasaki, Ryo Lewis, Richard A van Doorn, Pieter A